International collaborative ovarian neoplasm trial 1 and adjuvant chemotherapy in ovarian neoplasm trial: Two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma

Journal of the National Cancer Institute

Volumn 95, Issue 2, 2003, Pages 105-112

  Trimbos, J Baptist ^a   Parmar, Mahesh ^b   Vergote, Ignace ^c   Guthrie, David ^b   Bolis, Giorgio ^d   Colombo, Nicoletta ^e   Vermorken, Jan B ^f   Torri, Valter ^g   Mangioni, Costantino ^h   Pecorelli, Sergio ⁱ  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^f ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^g MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^h SAN GERARDO HOSPITAL   (Italy)

ⁱ UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CHROMIUM PHOSPHATE P 32; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; MELPHALAN; PLATINUM; TAXANE DERIVATIVE;

ABDOMINAL RADIOTHERAPY; ADULT; AGE; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL TYPE; CHI SQUARE TEST; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; OVARY CARCINOMA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZATION; RELIABILITY; SIDE EFFECT; TREATMENT INDICATION;

EID: 0037440207     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/95.2.105     Document Type: Article

References (25)